Recent Finacing
Recent Raise
SpineThera is a clinical-stage pharmaceutical company developing SX600, a months-long sustained-release dexamethasone epidural injection using a micro-suspension platform, conducting nonclinical toxicity testing and manufacturing scale-up for Phase 3.
